0001144204-12-008992.txt : 20120214 0001144204-12-008992.hdr.sgml : 20120214 20120214170949 ACCESSION NUMBER: 0001144204-12-008992 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111231 FILED AS OF DATE: 20120214 DATE AS OF CHANGE: 20120214 EFFECTIVENESS DATE: 20120214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001346824 IRS NUMBER: 830406777 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12884 FILM NUMBER: 12612418 BUSINESS ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 1200 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 1200 CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 v302378_13fhr.txt HOLDINGS REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2011 Check here if Amendment [ ]; Amendment Number: ---------- This Amendment (Check only one): [ ] is a restatement. [ ] adds new entries. Institutional Investment Manager Filing this Report: Name: RA Capital Management, LLC ------------------------------------------------------------------- Address: 20 Park Plaza, Suite 1200 ------------------------------------------------------------------- Boston, MA 02116 ------------------------------------------------------------------- Form 13F File Number: 28-12884 ------------------------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter Kolchinsky ------------------------------------------ Title: Manager ------------------------------------------ Phone: (617) 778-2500 ------------------------------------------ Signature, Place, and Date of Signing /s/ Peter Kolchinsky Boston, MA February 14, 2012 ------------------------------ ----------------------- ------------------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ---------------------- Form 13F Information Tabel Entry Total: 28 ---------------------- Form 13F Information Table Value Total: 166,591 ---------------------- (thousands) List of Other Included Managers: NONE FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------- -------- -------- -------- -------- -------- -------- -------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE / SHARED / NONE ------------------------------------------------------------------------------------------------------------------------------------ ACADIA PHARMACEUTICALS INC COM 004225 10 8 5,692 5,269,999 SH SOLE N/A 5,269,999 ARTHROCARE CORP COM 043136 10 0 13,512 426,505 SH SOLE N/A 426,505 COLUMBIA LABS INC COM 197779 10 1 8,526 3,410,573 SH SOLE N/A 3,410,573 DERMA SCIENCES INC COM PAR $.01 249827 50 2 7,909 1,043,419 SH SOLE N/A 1,043,419 DISCOVERY LABORATORIES INC N COM NEW 254668 40 3 219 130,497 SH SOLE N/A 130,497 DYAX CORP COM 26746E 10 3 8,425 6,195,201 SH SOLE N/A 6,195,201 DYNAVAX TECHNOLOGIES CORP COM 268158 10 2 2,158 650,000 SH SOLE N/A 650,000 ENDOCYTE INC COM 29269A 10 2 9,842 2,617,472 SH SOLE N/A 2,617,472 GENTIUM S P A SPONSORED ADR 37250B 10 4 2,959 486,662 SH SOLE N/A 486,662 IDENIX PHARMACEUTICALS INC COM 45166R 20 4 2,234 300,000 SH SOLE N/A 300,000 INHIBITEX INC COM 45719T 10 3 13,654 1,248,067 SH SOLE N/A 1,248,067 INHIBITEX INC COM 45719T 10 3 7,782 711,300 SH CALL SOLE N/A MELA SCIENCES INC COM 55277R 10 0 1,583 429,001 SH SOLE N/A 429,001 NEWLINK GENETICS CORP COM 651511 10 7 3,520 500,000 SH SOLE N/A 500,000 NOVAVAX INC COM 670002 10 4 1,221 969,072 SH SOLE N/A 969,072 ONCOGENEX PHARMACEUTICALS IN COM 68230A 10 6 8,663 737,923 SH SOLE N/A 737,923 POZEN INC COM 73941U 10 2 9,627 2,437,315 SH SOLE N/A 2,437,315 REPLIGEN CORP COM 759916 10 9 879 253,206 SH SOLE N/A 253,206 SANGAMO BIOSCIENCES INC COM 800677 10 6 2,459 865,884 SH SOLE N/A 865,884 SEQUENOM INC COM NEW 817337 40 5 20,558 4,619,800 SH SOLE N/A 4,619,800 SEQUENOM INC COM NEW 817337 40 5 6,675 1,500,000 SH CALL SOLE N/A SYNAGEVA BIOPHARMA CORP COM 87159A 10 3 8,370 314,302 SH SOLE N/A 314,302 TARGACEPT INC COM 87611R 30 6 557 100,000 SH SOLE N/A 100,000 TARGACEPT INC COM 87611R 30 6 113 20,300 SH CALL SOLE N/A TEARLAB CORP COM 878193 10 1 201 179,700 SH SOLE N/A 179,700 UROPLASTY INC COM NEW 917277 20 4 721 169,693 SH SOLE N/A 169,693 VANDA PHARMACEUTICALS INC COM 921659 10 8 11,566 2,429,914 SH SOLE N/A 2,429,914 VENTRUS BIOSCIENCES INC COM 922822 10 1 6,966 869,923 SH SOLE N/A 869,923